133 related articles for article (PubMed ID: 8485109)
1. Skin concentration of 8-methoxypsoralen, 5-methoxypsoralen and 4,5,8-trimethylpsoralen in guinea pigs.
Park YK; Hann SK; Im S; Kim S
J Dermatol Sci; 1993 Feb; 5(1):19-24. PubMed ID: 8485109
[TBL] [Abstract][Full Text] [Related]
2. Study of the skin concentrations after administration of the various phototoxic drugs.
Park YK; Hann SK; Cho MY; Kim HJ; Shim SC; Choi SJ; Yun MH
Yonsei Med J; 1991 Sep; 32(3):231-6. PubMed ID: 1781182
[TBL] [Abstract][Full Text] [Related]
3. Psoralens percutaneous permeation across the human whole skin and the epidermis in respect to their polarity (in vitro study).
Saïd A; Makki S; Muret P; Humbert P; Millet J
J Dermatol Sci; 1997 Feb; 14(2):136-44. PubMed ID: 9039977
[TBL] [Abstract][Full Text] [Related]
4. Bath PUVA--an investigation of the distribution of trioxsalen (TMP) and 8-methoxypsoralen (8-MOP) in bathwater.
Wainwright NJ; MacLeod TM; Ferguson J
Photodermatol Photoimmunol Photomed; 1997; 13(1-2):17-20. PubMed ID: 9361123
[TBL] [Abstract][Full Text] [Related]
5. Peak blistering point: influence on fluid levels of 5-MOP in human skin in vivo after systemic administration.
Humbert P; Treffel P; Makki S; Millet J; Agache P
Arch Dermatol Res; 1991; 283(5):297-9. PubMed ID: 1929553
[TBL] [Abstract][Full Text] [Related]
6. The effect of UVA irradiation on the epidermal melanocyte after 8-MOP and TMP administration.
Park YK; Hann SK; Cho MY; Hahn CS; Kim HJ; Hong KT
J Dermatol Sci; 1990 Sep; 1(5):355-9. PubMed ID: 2127374
[TBL] [Abstract][Full Text] [Related]
7. 8-Methoxypsoralen levels in blood of vitiligo patients and in skin, ophthalmic fluids, and ocular tissues of the guinea pig.
Chakrabarti SG; Halder RM; Johnson BA; Minus HR; Pradhan TK; Kenney JA
J Invest Dermatol; 1986 Aug; 87(2):276-9. PubMed ID: 3734475
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of 8-methoxypsoralen and 5-methoxypsoralen distribution in guinea pig serum, epidermis and ocular lens.
Wamer W; Giles A; Kornhauser A
Photodermatol; 1987 Oct; 4(5):236-9. PubMed ID: 3697346
[TBL] [Abstract][Full Text] [Related]
9. Safety and therapeutic effectiveness of 8-methoxypsoralen, 4,5',8-trimethylpsoralen, and psoralen in vitiligo.
Pathak MA; Mosher DB; Fitzpatrick TB
Natl Cancer Inst Monogr; 1984 Dec; 66():165-73. PubMed ID: 6531024
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of [14C-5] 8-methoxypsoralen distribution in rabbits.
Malinin GI; Glew WB; Roberts WP; Townsend L; Nigra TP
Arch Dermatol Res; 1982; 273(3-4):319-26. PubMed ID: 7165357
[TBL] [Abstract][Full Text] [Related]
11. An intraindividual comparative study of psoralen-UVA erythema induced by bath 8-methoxypsoralen and 4, 5', 8-trimethylpsoralen.
Man I; McKinlay J; Dawe RS; Ferguson J; Ibbotson SH
J Am Acad Dermatol; 2003 Jul; 49(1):59-64. PubMed ID: 12833009
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of the anti-psoriatic agent 5-methoxypsoralen in humans: comparison with rat and dog.
John BA; Chasseaud LF; Wood SG; Forlot P
Xenobiotica; 1992 Nov; 22(11):1339-51. PubMed ID: 1492426
[TBL] [Abstract][Full Text] [Related]
13. Difference in topical and systemic reactivity of psoralens: determinations of epidermal and serum levels.
Kornhauser A; Wamer WG; Giles AL
Natl Cancer Inst Monogr; 1984 Dec; 66():97-101. PubMed ID: 6531046
[TBL] [Abstract][Full Text] [Related]
14. Psoralen phototoxicity: correlation with serum and epidermal 8-methoxypsoralen and 5-methoxypsoralen in the guinea pig.
Kornhauser A; Wamer WG; Giles AL
Science; 1982 Aug; 217(4561):733-5. PubMed ID: 7100920
[TBL] [Abstract][Full Text] [Related]
15. Greater promotion in sister chromatid exchanges by trimethylpsoralen than by 8-methoxypsoralen in the presence of UV-light.
Gaynor AL; Carter DM
J Invest Dermatol; 1978 Oct; 71(4):257-9. PubMed ID: 701845
[TBL] [Abstract][Full Text] [Related]
16. Effect of UV-B erythema of psoralen, trimethylpsoralen, and 8 methoxypsoralen.
Coupez L; Agache PG; Petigny M
Acta Derm Venereol; 1980; 60(5):456-9. PubMed ID: 6162327
[TBL] [Abstract][Full Text] [Related]
17. Comparative bacterial mutagenicity studies with 8-methoxypsoralen and 4,5',8-trimethylpsoralen in the presence of near-ultraviolet light and in the dark.
Kirkland DJ; Creed KL; Mannisto P
Mutat Res; 1983 Feb; 116(2):73-82. PubMed ID: 6338360
[TBL] [Abstract][Full Text] [Related]
18. Methoxypsoralen phototherapy of transitional cell carcinoma.
Keane TE; Petros JA; Velimirovich B; Yue KT; Graham SD
Urology; 1994 Dec; 44(6):842-6. PubMed ID: 7985313
[TBL] [Abstract][Full Text] [Related]
19. Dietary intake and risk assessment of phototoxic furocoumarins in humans.
Schlatter J; Zimmerli B; Dick R; Panizzon R; Schlatter C
Food Chem Toxicol; 1991 Aug; 29(8):523-30. PubMed ID: 1894218
[TBL] [Abstract][Full Text] [Related]
20. Serum free 5-methoxypsoralen fraction in health and psoriasis: relationship with human serum albumin concentration.
Muret P; Humbert P; Makki S; Bechtel P; Urien S; Tillement JP
Arch Dermatol Res; 1993; 285(5):287-90. PubMed ID: 8379689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
